Brought to you by:
IN.PACT Admiral DCB shows ‘significant advantage’ over uncoated devices in fempop artery treatment analysis
The IN.PACT Admiral drug-coated balloon (DCB) demonstrated a significant advantage in overall survival, amputation-free survival and target-lesion revascularization after femoropopliteal artery treatment through four-year follow-up when compared to uncoated balloons, a single-institution, retrospective review that tackled a head-to-head comparison between…
September slate of regional vascular meetings goes digital
This time last year, the ranks of vascular surgery were gearing up to head for points East, West, Midwest and Northeast as the slew of key regional meetings that take place in the early fall entered their viewfield. But like…